Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/04/2789962/0/en/Cyclerion-Appoints-Regina-Graul-Ph-D-as-President.html
https://www.globenewswire.com//news-release/2023/11/30/2789032/0/en/Cyclerion-Strengthens-Board-of-Directors-with-Experienced-Company-Builder-and-Cutting-edge-Innovator.html
https://www.globenewswire.com/news-release/2023/07/31/2714726/0/en/Tisento-Launches-with-81-Million-From-Top-Tier-Investor-Syndicate-and-Promising-Cyclerion-Assets.html
https://www.globenewswire.com/news-release/2023/06/01/2680799/0/en/Cyclerion-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html
https://www.globenewswire.com/news-release/2023/05/15/2669165/0/en/Cyclerion-Announces-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2023/05/11/2667449/0/en/Cyclerion-Announces-Definitive-Agreement-for-Zagociguat-and-CY3018.html
https://www.globenewswire.com/news-release/2023/05/11/2667451/0/en/Cyclerion-Announces-Corporate-Updates-and-Q1-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/03/27/2634605/0/en/Cyclerion-Therapeutics-Receives-U-S-FDA-Orphan-Drug-Designation-for-Zagociguat-for-the-Treatment-of-Mitochondrial-Diseases.html
https://endpts.com/hard-pressed-for-cash-cyclerion-looks-for-help-funding-rare-disease-drug/
https://www.globenewswire.com/news-release/2023/03/22/2632740/0/en/Cyclerion-Reports-Corporate-Update-and-Full-Year-2022-Financial-Results.html